In this study, we have shown that the knock-in of the EGFR C797S mutation is associated with elevated expression of AXL and that inhibition of AXL is effective in slowing the growth of NSCLC cells harboring EGFR C797S. This evidence concerns the gene EGFR and non-small cell lung carcinoma.